These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17354042)

  • 1. The application of positron-emitting molecular imaging tracers in Alzheimer's disease.
    Cohen RM
    Mol Imaging Biol; 2007; 9(4):204-16. PubMed ID: 17354042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography.
    Timmers T; van Berckel BNM; Lammertsma AA; Ossenkoppele R
    Methods Mol Biol; 2018; 1750():221-229. PubMed ID: 29512076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
    Shin J; Lee SY; Kim SH; Kim YB; Cho SJ
    Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography.
    Klunk WE; Engler H; Nordberg A; Bacskai BJ; Wang Y; Price JC; Bergström M; Hyman BT; Långström B; Mathis CA
    Neuroimaging Clin N Am; 2003 Nov; 13(4):781-9, ix. PubMed ID: 15024961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.
    Villemagne VL; Rowe CC; Macfarlane S; Novakovic KE; Masters CL
    J Clin Neurosci; 2005 Apr; 12(3):221-30. PubMed ID: 15851069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Nordberg A
    Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amyloid-plaque imaging of the brain using PET].
    Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
    Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurobiology and molecular biology of Alzheimer's disease].
    DeKosky ST
    Rev Neurol; 2002 Oct 16-31; 35(8):752-60. PubMed ID: 12402229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
    Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
    J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
    Luan K; Rosales JL; Lee KY
    Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal PET tracers for Alzheimer's disease.
    Prem Kumar A; Singh N; Nair D; Justin A
    Biochem Biophys Res Commun; 2022 Jan; 587():58-62. PubMed ID: 34864547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles.
    Mesulam MM
    Neuron; 1999 Nov; 24(3):521-9. PubMed ID: 10595506
    [No Abstract]   [Full Text] [Related]  

  • 18. The merits of FDDNP-PET imaging in Alzheimer's disease.
    Shin J; Kepe V; Barrio JR; Small GW
    J Alzheimers Dis; 2011; 26 Suppl 3():135-45. PubMed ID: 21971458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
    Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
    Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.